Prognostic impact of rapid reduction of involved free light chains in multiple myeloma patients under first-line treatment with Bendamustine, Prednisone, and Bortezomib (BPV) | SpringerLink
Diagnostic and mechanistic implications of serum free light chains, albumin and alpha-fetoprotein in hepatocellular carcinoma | British Journal of Cancer
Frontiers | H-TEX-mediated signaling between hepatocellular carcinoma cells and macrophages and exosome-targeted therapy for hepatocellular carcinoma
Cerebrospinal fluid kappa free light chains as biomarker in multiple sclerosis—from diagnosis to prediction of disease activity | SpringerLink
Serum free light chain analysis - Davids - 2010 - American Journal of Hematology - Wiley Online Library
Blood stem cell transplantation to treat cystic lung light chain deposition disease | European Respiratory Society
FREE LIGHT CHAINS (SERUM) | LABCORP OKLAHOMA INC.
Extraosseous myeloma of liver mimicking multifocal hepatocellular carcinoma where a distinction has to be made: two case reports | HKMJ
Cardiac Light Chain Deposition Disease Mimicking Immunoglobulin Light Chain Amyloidosis | Circulation: Cardiovascular Imaging
Cancers | Free Full-Text | Immunoglobulin M Paraproteinaemias
Mono/polyclonal free light chains as challenging biomarkers for immunological abnormalities - ScienceDirect
Serum free light chain assessment in monoclonal gammopathy and kidney disease | Nature Reviews Nephrology
Light-chain deposit disease
The role of free kappa and lambda light chains in the pathogenesis and treatment of inflammatory diseases - ScienceDirect
Diagnostics | Free Full-Text | The Current Role of the Heavy/Light Chain Assay in the Diagnosis, Prognosis and Monitoring of Multiple Myeloma: An Evidence-Based Approach
The pathogenesis of renal injury and treatment in light chain deposition disease | Journal of Translational Medicine | Full Text
Malignant cells presenting plasmacytoid diff erentiation and kappa... | Download Scientific Diagram
Red Flag Presentations of Immunoglobulin Light Chain Amyloidosis in Patients With Multiple Myeloma - The ASCO Post
Frontiers | “Complimenting the Complement”: Mechanistic Insights and Opportunities for Therapeutics in Hepatocellular Carcinoma
Intrathecal kappa free light chains as markers for multiple sclerosis | Scientific Reports
Cancers | Free Full-Text | Prognostic Impact of Serum Free Light Chain Ratio Normalization in Patients with Multiple Myeloma Treated within the GMMG-MM5 Trial
Light Chain-Associated Renal Disorders: Practice Essentials, Pathophysiology, Etiology
Cancers | Free Full-Text | Monoclonal Gammopathy of Undetermined Significance (MGUS)—Not So Asymptomatic after All
Light chain deposition disease involving kidney and liver in a patient with IgD myeloma | BMC Nephrology | Full Text
